Literature DB >> 9714853

Insulin occludes leptin activation of ATP-sensitive K+ channels in rat CRI-G1 insulin secreting cells.

J Harvey1, M L Ashford.   

Abstract

1. Using whole-cell and cell-attached recording configurations, the effects of insulin on leptin activation of ATP-sensitive K+ (KATP) channels were examined in the CRI-G1 insulinoma cell line. 2. Whole-cell recordings demonstrated that the leptin-induced hyperpolarization and increased potassium conductance are completely occluded by prior exposure to insulin (1-50 nM). In cell-attached recordings, insulin prevented leptin activation of tolbutamide-sensitive KATP channels. Furthermore, insulin (50 nM) slowly and completely reversed the effects of leptin (10 nM), an action not attributable to direct inhibition of KATP channels per se. 3. Low concentrations of insulin-like growth factor-1 (IGF-1; 10-100 nM) failed to prevent leptin activation of KATP channels, although higher concentrations (1 microM) did inhibit leptin actions. 4. The action of insulin was specific for leptin, as the hyperglycaemic agent diazoxide activated KATP channels following prior exposure to insulin. 5. Wortmannin (1-10 nM) and LY 294002 (10 microM) prevented leptin activation of KATP channels, indicating an involvement of phosphoinositide 3-kinase (PI 3-kinase). 6. In conclusion, leptin activation of KATP channels is counter-regulated by insulin in the CRI-G1 insulinoma cell line. This feedback mechanism may be important in the local integration of hormonal signals which regulate insulin secretion and in alterations of metabolic homeostasis associated with obesity and non-insulin dependent diabetes mellitus (NIDDM).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714853      PMCID: PMC2231169          DOI: 10.1111/j.1469-7793.1998.695bg.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  33 in total

1.  Leptin activates ATP-sensitive potassium channels in the rat insulin-secreting cell line, CRI-G1.

Authors:  J Harvey; F McKenna; P S Herson; D Spanswick; M L Ashford
Journal:  J Physiol       Date:  1997-11-01       Impact factor: 5.182

Review 2.  Agonist-stimulated synthesis of phosphatidylinositol(3,4,5)-trisphosphate: a new intracellular signalling system?

Authors:  L R Stephens; T R Jackson; P T Hawkins
Journal:  Biochim Biophys Acta       Date:  1993-10-07

3.  Identification of functional insulin receptors on membranes from an insulin-producing cell line (RINm5F).

Authors:  H Gazzano; P Halban; M Prentki; R Ballotti; D Brandenburg; M Fehlmann; E Van Obberghen
Journal:  Biochem J       Date:  1985-03-15       Impact factor: 3.857

4.  Five new insulin-producing cell lines with differing secretory properties.

Authors:  C A Carrington; E D Rubery; E C Pearson; C N Hales
Journal:  J Endocrinol       Date:  1986-05       Impact factor: 4.286

5.  Insulin receptor substrate-1 mediates phosphatidylinositol 3'-kinase and p70S6k signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation.

Authors:  M G Myers; T C Grammer; L M Wang; X J Sun; J H Pierce; J Blenis; M F White
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

6.  Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.

Authors:  G Powis; R Bonjouklian; M M Berggren; A Gallegos; R Abraham; C Ashendel; L Zalkow; W F Matter; J Dodge; G Grindey
Journal:  Cancer Res       Date:  1994-05-01       Impact factor: 12.701

7.  Hyperinsulinaemia in obesity is not accompanied by an increase in serum proinsulin/insulin ratio in groups of human subjects with and without glucose intolerance.

Authors:  I Shiraishi; Y Iwamoto; T Kuzuya; A Matsuda; S Kumakura
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

8.  Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line.

Authors:  N C Sturgess; R Z Kozlowski; C A Carrington; C N Hales; M L Ashford
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

9.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

10.  Effects of the obese gene product on body weight regulation in ob/ob mice.

Authors:  M A Pelleymounter; M J Cullen; M B Baker; R Hecht; D Winters; T Boone; F Collins
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

View more
  6 in total

Review 1.  Leptin in human physiology and pathophysiology.

Authors:  Christos S Mantzoros; Faidon Magkos; Mary Brinkoetter; Elizabeth Sienkiewicz; Tina A Dardeno; Sang-Yong Kim; Ole-Petter R Hamnvik; Anastasia Koniaris
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-26       Impact factor: 4.310

2.  Leptin activation of ATP-sensitive K+ (KATP) channels in rat CRI-G1 insulinoma cells involves disruption of the actin cytoskeleton.

Authors:  J Harvey; S C Hardy; A J Irving; M L Ashford
Journal:  J Physiol       Date:  2000-08-15       Impact factor: 5.182

3.  Concerted Trafficking Regulation of Kv2.1 and KATP Channels by Leptin in Pancreatic β-Cells.

Authors:  Yi Wu; Show-Ling Shyng; Pei-Chun Chen
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

4.  Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus.

Authors:  J Seufert; T J Kieffer; C A Leech; G G Holz; W Moritz; C Ricordi; J F Habener
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

Review 5.  Leptin: a multifaceted hormone in the central nervous system.

Authors:  Jenni Harvey
Journal:  Mol Neurobiol       Date:  2003-12       Impact factor: 5.590

6.  The aminoguanidine carboxylate BVT.12777 activates ATP-sensitive K+ channels in the rat insulinoma cell line, CRI-G1.

Authors:  Jackie M Kinsella; Hilary A Laidlaw; Teresa Tang; Jenni Harvey; Calum Sutherland; Michael L J Ashford
Journal:  BMC Pharmacol       Date:  2004-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.